All In Biotech

Drug Trial Radar · NCT01560624

Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy

A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy

Last checked: Nov 19, 2026Latest source record: Feb 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 690 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

690

Actual

Start

Jun 26, 2012

Primary completion

Jun 24, 2018

Study completion Jun 24, 2018

Sponsor

Lead sponsor
United TherapeuticsIndustry
Sponsor type
Industry
First posted
Mar 22, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an international, multicenter, randomized, double-blind, placebo-controlled, event driven study in subjects with pulmonary arterial hypertension.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • Treprostinil DiolamineDrug

    Active

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to First Clinical Worsening EventTime frame: From randomization to approximately 4 years

Locations

155 sites in 23 countries. Site status is shown where the registry gives one.

  • Arizona Pulmonary Specialists, Ltd.

    Phoenix, Arizona

  • University of Arizona

    Tucson, Arizona

  • University of California, San Francisco-Fresno

    Fresno, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • University of California-Davis Medical Group, Advanced Lung Disease/Transplant Program

    Sacramento, California

  • David Geffen School of Medicine

    Torrance, California

  • University of Colorado Hospital

    Aurora, Colorado

  • University of Florida

    Gainesville, Florida

  • University of Florida College of Medicine Jacksonville- Division of Pulmonary & Critical Medicine

    Jacksonville, Florida

  • University of Florida College of Medicine Jacksonville

    Jacksonville, Florida

  • University of Florida College of Medicine, Jacksonville

    Jacksonville, Florida

  • Cleveland Clinic Florida

    Weston, Florida

  • Emory University Hospital

    Atlanta, Georgia

  • Augusta University

    Augusta, Georgia

  • Piedmont - Georgia Lung Associates

    Austell, Georgia

  • HeartCare Midwest

    Peoria, Illinois

  • Indiana University Hospital

    Carmel, Indiana

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Kentuckiana Pulmonary Associates

    Louisville, Kentucky

  • University of Maryland

    Baltimore, Maryland

  • Tufts Medical Center

    Boston, Massachusetts

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Henry Ford Health System

    Detroit, Michigan

  • Beaumont Health

    Troy, Michigan

  • Nebraska Medical Center

    Omaha, Nebraska

  • Newark Beth Israel Medical Center

    Newark, New Jersey

  • University of Rochester

    Rochester, New York

  • Asheville Cardiology Associates

    Asheville, North Carolina

  • University of Cincinnati

    Cincinnati, Ohio

  • University Hospital

    Cleveland, Ohio

  • The Ohio State University

    Columbus, Ohio

  • Oregon Health and Science University

    Portland, Oregon

  • Legacy Research Institute

    Portland, Oregon

  • Perelman Center for Advanced Medicine; University of Pennsylvania

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center - Presbyterian Cardiovascular Institute

    Pittsburgh, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • The University of Texas Health Science Center at Houston

    Houston, Texas

  • Sentara Cardiovascular Research Institute

    Norfolk, Virginia

  • Virginia Commonwealth University

    Richmond, Virginia

  • Aurora Saint Luke's Medical Center

    Milwaukee, Wisconsin

Showing 40 of 155 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.